Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 15, 2022
Immunitas Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Cancer Immunotherapy IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting November 15, 2022
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 15, 2022
Werewolf Therapeutics to Present Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting November 8, 2022
Channel Medsystems Announces Publication of Long-term Clinical Outcomes with Cerene® Cryotherapy for the Treatment of Heavy Menstrual Bleeding October 27, 2022
